Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

Bookmark and Share
Published: 25 Jun 2009
Views: 13771
Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland
Study to evaluate the frequency of complete pathologic response after neo-adjuvant treatment with cisplatin chemotherapy in women with breast cancer and a BRCA1 mutation.